On the heels of a fall and winter that saw hundreds of Alberta babies and toddlers hospitalized and two young children die ...

There have been almost 50,000 cases of RSV recorded this year, but only a select group can access the free vaccine, with ...

The American Academy of Pediatrics has said childhood vaccines are carefully studied in randomized controlled trials — ...

It teased the positive results in July. Along with Beyfortus (nirsevimab), it is also a potential rival to Pfizer's RSV vaccine Abrysvo, which can be given to women during pregnancy to protect ...

AstraZeneca and Sanofi have secured approval in the EU for Beyfortus, the first single-dose drug to protect newborns and infants from respiratory syncytial virus (RSV) infections. The antibody ...

RSV-NET data showed that RSV hospitalization rates among infants aged 0 to 7 months were an estimated 43% (95% confidence ...

Beyfortus, and GSK’s Rotarix and Merck’s RotaTeq, the two rotavirus vaccines licensed for use in the United States. Some of the currently available vaccines were tested by comparing them to ...

Q1 2025 Earnings Conference Call May 15, 2025 8:30 AM ETCompany ParticipantsKatie Falzone - Senior Vice President, ...